A Recombinant Vesicular Stomatitis Virus-Based Vaccine Provides Postexposure Protection Against Bundibugyo Ebolavirus Infection

Woolsey, C; Strampe, J; Fenton, KA; Agans, KN; Martinez, J; Borisevich, V; Dobias, NS; Deer, DJ; Geisbert, JB; Cross, RW; Connor, JH; Geisbert, TW

Geisbert, TW (通讯作者),Univ Texas Med Branch, Galveston Natl Lab, 301 Univ Blvd, Galveston, TX 77555 USA.

JOURNAL OF INFECTIOUS DISEASES, 2023; 228 (): S712

Abstract

Background The filovirus Bundibugyo virus (BDBV) causes severe disease with a mortality rate of approximately 20%-51%. The only licensed filovirus vac......

Full Text Link